Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Zeijl, C.J.J. van"'
Autor:
Ommen-Nijhof, A. van, Konings, I.R., Zeijl, C.J.J. van, Uyl-de Groot, C.A., Noort, V. van der, Jager, A., Sonke, G.S., SONIA Study Steering Comm
Publikováno v:
SONIA study steering committee 2018, ' Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer-the SONIA study: study protocol for a randomized controlled trial ', BMC Cancer, vol. 18, no. 1, pp. 1146 . https://doi.org/10.1186/s12885-018-4978-1
BMC Cancer, 18(1). BioMed Central
BMC Cancer, 18:1146. BioMed Central Ltd.
BMC Cancer, 18
BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)
BMC Cancer, 18(1):1146. BMC
BMC Cancer
BMC Cancer, 18(1). BioMed Central
BMC Cancer, 18:1146. BioMed Central Ltd.
BMC Cancer, 18
BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)
BMC Cancer, 18(1):1146. BMC
BMC Cancer
Background Combining cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors with endocrine therapy is an effective strategy to improve progression-free survival in hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-negativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d1197520145ef55497d745567ee56e
https://research.vumc.nl/en/publications/f57d9715-4d49-4a3b-b5d2-0b77d521d047
https://research.vumc.nl/en/publications/f57d9715-4d49-4a3b-b5d2-0b77d521d047